A report from Global Industry Analysts estimates the worldwide market for cardiovascular PACS will grow to $891 million by 2017. Fueling the growth are higher cardiac disease rates and demand created by advances in modalities such as PET/CT and SPECT, among other factors. The U.S. and Europe are the two biggest regional markets for cardiovascular PACS, the report says.

Related Summaries